99 related articles for article (PubMed ID: 10940709)
1. Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma.
Shimazui T; Oosterwijk-Wakka J; Akaza H; Bringuier PP; Ruijter E; Debruyne FM; Schalken JA; Oosterwijk E
Eur Urol; 2000 Sep; 38(3):331-8. PubMed ID: 10940709
[TBL] [Abstract][Full Text] [Related]
2. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma.
Paul R; Ewing CM; Robinson JC; Marshall FF; Johnson KR; Wheelock MJ; Isaacs WB
Cancer Res; 1997 Jul; 57(13):2741-8. PubMed ID: 9205085
[TBL] [Abstract][Full Text] [Related]
3. Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts.
Tani T; Laitinen L; Kangas L; Lehto VP; Virtanen I
Int J Cancer; 1995 Dec; 64(6):407-14. PubMed ID: 8550243
[TBL] [Abstract][Full Text] [Related]
4. Expression of cadherin-8 in renal cell carcinoma and fetal kidney.
Blaschke S; Mueller CA; Markovic-Lipkovski J; Puch S; Miosge N; Becker V; Mueller GA; Klein G
Int J Cancer; 2002 Oct; 101(4):327-34. PubMed ID: 12209956
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma.
Thedieck C; Kuczyk M; Klingel K; Steiert I; Müller CA; Klein G
Br J Cancer; 2005 Jun; 92(11):2010-7. PubMed ID: 15886705
[TBL] [Abstract][Full Text] [Related]
6. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
Shimazui T; Oosterwijk E; Akaza H; Bringuier P; Ruijter E; van Berkel H; Wakka JO; van Bokhoven A; Debruyne FM; Schalken JA
Clin Cancer Res; 1998 Oct; 4(10):2419-24. PubMed ID: 9796973
[TBL] [Abstract][Full Text] [Related]
7. Complex cadherin expression in renal cell carcinoma.
Shimazui T; Giroldi LA; Bringuier PP; Oosterwijk E; Schalken JA
Cancer Res; 1996 Jul; 56(14):3234-7. PubMed ID: 8764114
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma.
Shimazui T; Bringuier PP; van Berkel H; Ruijter E; Akaza H; Debruyne FM; Oosterwijk E; Schalken JA
Int J Cancer; 1997 Oct; 74(5):523-8. PubMed ID: 9355975
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma.
Kuroiwa K; Konomoto T; Kumazawa J; Naito S; Tsuneyoshi M
J Surg Oncol; 2001 Jun; 77(2):123-31. PubMed ID: 11398166
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
Shimazui T; Kojima T; Onozawa M; Suzuki M; Asano T; Akaza H
Oncol Rep; 2006 May; 15(5):1181-4. PubMed ID: 16596183
[TBL] [Abstract][Full Text] [Related]
11. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
12. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.
Wakatsuki S; Watanabe R; Saito K; Saito T; Katagiri A; Sato S; Tomita Y
Cancer Lett; 1996 May; 103(1):11-7. PubMed ID: 8616803
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
14. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats.
Jung KY; Dean D; Jiang J; Gaylor S; Griffith WH; Burghardt RC; Parrish AR
Mech Ageing Dev; 2004 Jun; 125(6):445-53. PubMed ID: 15178134
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic carcinoma: correlation between E-cadherin and alpha-catenin expression status and liver metastasis.
Gunji N; Oda T; Todoroki T; Kanazawa N; Kawamoto T; Yuzawa K; Scarpa A; Fukao K
Cancer; 1998 May; 82(9):1649-56. PubMed ID: 9576284
[TBL] [Abstract][Full Text] [Related]
16. Neuronal circuits are subdivided by differential expression of type-II classic cadherins in postnatal mouse brains.
Suzuki SC; Inoue T; Kimura Y; Tanaka T; Takeichi M
Mol Cell Neurosci; 1997; 9(5-6):433-47. PubMed ID: 9361280
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma.
Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M; Darewicz B
Acta Biochim Pol; 2017; 64(3):465-470. PubMed ID: 28742884
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of β-catenin, E-cadherin and N-cadherin in neonate and adult rat kidney.
Terada N; Karim MR; Izawa T; Kuwamura M; Yamate J
J Vet Med Sci; 2017 Nov; 79(11):1785-1790. PubMed ID: 28993569
[TBL] [Abstract][Full Text] [Related]
19. Correlation of E-cadherin and alpha-catenin expression with differentiation of oral squamous cell carcinoma.
Sakaki T; Wato M; Tamura I; Nakajima M; Morita S; Kakudo K; Shirasu R; Tanaka A; Sakaki T
J Osaka Dent Univ; 1999 Oct; 33(2):75-81. PubMed ID: 10863478
[TBL] [Abstract][Full Text] [Related]
20. Classical cadherins in urological cancers.
Giroldi LA; Shimazui T; Schalken JA; Yamasaki H; Bringuier PP
Morphologie; 2000 Jun; 84(265):31-8. PubMed ID: 11048296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
